StonvexLoading…
StonvexStonvexStonvexCore line items from PENN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $6.36B | $6.40B | $5.91B | $3.58B |
Operating Income | $-690.20M | $974.00M | $1.06B | $-410.20M |
Net Income | $-490.00M | $222.10M | $420.80M | $-669.50M |
EPS (Diluted) | $-3.22 | $1.29 | $2.48 | $-5.00 |
Total Assets | $16.06B | $17.50B | $16.87B | $14.67B |
Total Liabilities | $12.86B | $13.91B | $12.78B | $12.01B |
Cash & Equivalents | $1.07B | $1.62B | $1.86B | $1.85B |
Free Cash Flow OCF − CapEx | $95.90M | $614.80M | $652.00M | $201.80M |
Shares Outstanding | 152.10M | 176.60M | 175.50M | 155.70M |